Analyst consensus rating
Polaryx Therapeutics Analyst Rating: Strong Buy
Direct answer
Polaryx Therapeutics's consensus rating is Strong Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $7.50.
Forecast evidence checked November 12, 2026.
Get free Polaryx Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.95
- Average price target
- $7.50
- High price target
- $10.00
- Low price target
- $6.00
- Low target gap
- +207.7%
- Target upside
- +284.6%
- High target gap
- +412.8%
- Target range width
- 205.1%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- November 12, 2026
- Valid through
- November 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Polaryx Therapeutics?
Polaryx Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $7.50.
How far are Polaryx Therapeutics's low and high targets from the recorded price?
The low target implies +207.7%, while the high target implies +412.8%.
How many analysts are included in Polaryx Therapeutics's consensus?
The verified consensus includes 4 analysts.
How is Polaryx Therapeutics's target upside or downside calculated?
The average target of $7.50 is divided by the recorded price of $1.95, then one is subtracted to produce +284.6%. This does not guarantee a future return.
When was Polaryx Therapeutics's analyst forecast verified?
The data was verified on 2026-11-12. The dataset is valid through 2026-11-19.